The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
7023068 7418288 F 7023068-5 20100908 20100916 20100930 EXP PHHY2010CA36044 NOVARTIS PHARMACEUTICAL CORPORATION 56 YR M Y 20100930 OT CANADA

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
7023068 1014812594 PS ZOMETA 1 INTRAVENOUS 4 MG, EVERY 4 WEEKS 021223

Indications of drugs used

Event ID DRUG SEQ INDI PT
7023068 1014812594 PROSTATE CANCER METASTATIC

Outcome of event

Event ID OUTC COD
7023068 OT

Reactions reported

Event ID PT
7023068 ABDOMINAL DISTENSION
7023068 ARTHRITIS
7023068 BLOOD CHLORIDE DECREASED
7023068 BLOOD POTASSIUM DECREASED
7023068 BLOOD PRESSURE INCREASED
7023068 FIBROMYALGIA
7023068 GASTROOESOPHAGEAL REFLUX DISEASE
7023068 MUSCULOSKELETAL STIFFNESS
7023068 PAIN

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
7023068 1014812594 20100526